From Proteomic Analysis to Clinical Significance
Shilei Ding,Yan Li,Ye Tan,Man Jiang,Bo Tian,Ying Kun Liu,Xiaofeng Shao,Sheng Long Ye,Jia Wu,Rong Zeng,Hong Yang Wang,Zhao You Tang,Qing Xia
DOI: https://doi.org/10.1074/mcp.m300094-mcp200
IF: 7.381
2004-01-01
Molecular & Cellular Proteomics
Abstract:To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases (satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases (satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. Metastasis is the most life-threatening event in cancer patients. For hepatocellular carcinoma (HCC), 1The abbreviations used are: HCC, hepatocellular carcinoma; CK, cytokeratin; 2-DE, two-dimensional electrophoresis; IEF, isoelectric focusing; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; MS, mass spectrometry; IF, intermediate filament; TNM, tumor node metastasis; AFP, α-fetoprotein.1The abbreviations used are: HCC, hepatocellular carcinoma; CK, cytokeratin; 2-DE, two-dimensional electrophoresis; IEF, isoelectric focusing; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; MS, mass spectrometry; IF, intermediate filament; TNM, tumor node metastasis; AFP, α-fetoprotein. the fourtth leading cause of cancer death worldwide and the second in China, surgery remains the treatment of choice, but the 5-year recurrence rate after section is as high as 40–70% (1Tang Z.Y. Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence..Gastroenterol. Today. 2000; 4: 191-195Google Scholar). Metastatic recurrence is the main obstacle to the improvement of treatment efficacy. Pathologic factors indicative of tumor invasiveness such as portal vein invasion, intrahepatic metastasis, presence of satellite nodules, large tumor size, and advanced tumor node metastasis (TNM) stage, are the best-established risk factors for recurrence (2Qin X.L. Tang Z.Y. The prognostic significance of clinical and pathological features in hepatocellular carcinoma..World J. Gastroenterol. 2002; 8: 193-199Google Scholar). However, the molecular events promoting invasiveness of HCC cells are still hardly known and routine biomarkers for HCC prognosis are not yet available. For a better insight into the mechanisms of HCC metastasis, a high metastatic human HCC cell line, MHCC97, its clonal cells, MHCC97-H and MHCC97-L, with high and low metastatic potentials, and progressively more metastatic cells from lung metastatic lesions were established via repeated in vivo selection (3Tian J. Tang Z.Y. Ye S.L. Liu Y.K. Lin Z.Y. Chen J. Xue Q. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis..Br. J. Cancer. 1999; 81: 814-818Google Scholar, 4Li Y. Tang Z.Y. Ye S.L. Liu Y.K. Chen J. Xue Q. Chen J. Gao D.M. Bao W.H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97..World J. Gastroenterol. 2001; 7: 630-636Google Scholar, 5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). These cells provide appropriate model systems with similar genetic background for the comparative study on the molecular events involved in HCC metastasis. Among the currently available techniques, proteomics permits the analysis of thousands of modified or unmodified proteins simultaneously and becomes increasingly popular for identifying biomarkers for early detection, classification, and prognosis of tumors, as well as pinpointing targets for improved treatment outcomes (6Simpson R.J. Dorow D.S. Cancer proteomics: from signaling networks to tumor markers..Trends Biotech. 2001; 19: 40-48Abstract Full Text Full Text PDF Google Scholar). We had used this approach to identify differentially expressed proteins between human HCC and normal liver cell line and investigated malignant growth-associated proteins in human hepatoma cells transfected with antisense-epidermal growth factor receptor (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar, 8Yu L.R. Shao X.X. Jiang W.L. Xu D. Chang Y.C. Xu Y.H. Xia Q.C. Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence..Electrophoresis. 2001; 22: 3001-3008Google Scholar). In this study, this technique was combined with immunology methods to study MHCC97-H and MHCC97-L for screening metastasis-associated proteins. Cytokeratins represent important structural components of the epithelial cytoskeleton, and their expression is remarkably tissue specific, suggesting that the type of cytokeratins present in the cells is related to their biological function (9Moll R. Franke W.W. Schiller D.L. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells..Cell. 1982; 31: 11-24Google Scholar). Recent studies have indicated that cytokeratins play an important role in the regulation of cell migration and invasion. The accumulation of cytokeratin 16 (CK16) correlated with a re-organization of keratin filaments to a perinuclear position away from the direction of migration as a prerequisite for cell migration into the wound site (10Paladini R.D. Takahashi K. Bravo N.S. Coulombe P.A. Onset of reepithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16..J. Cell Biol. 1996; 132: 381-397Google Scholar). Cell transfected with human cytokeratin 8 (CK8) and cytokeratin 18 (CK18) had higher migratory and invasive abilities (11Chu Y.W. Runyan R.B. Oshima R.G. Hendrix M.J. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion..Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 4261-4265Google Scholar). Direct evidence has been provided to link overexpression of cytokeratins in human melanoma with increased migratory and invasive activity in vitro (12Hendrix M.J. Seftor E.A. Chu Y.W. Trevor K.T. Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis..Cancer Metastasis Rev. 1996; 15: 507-525Google Scholar). The mechanism responsible for the differential expression of metastatic properties rests in the unique interaction, either direct or indirect, of cytokeratin intermediate filaments (IFs) with specific integrins interacting with the extracellular matrix (12Hendrix M.J. Seftor E.A. Chu Y.W. Trevor K.T. Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis..Cancer Metastasis Rev. 1996; 15: 507-525Google Scholar, 13Crowe D.L. Milo G.E. Shuler C.F. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential..J. Dent. Res.,. 1999; 78: 1256-1263Google Scholar). Here cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L by proteomic approach. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases. Serum CK19 fragment CYFRA 21-1 levels in nude mice model demonstrated that CK19 might be a useful marker for predicting the possibility of tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. MHCC97-H and MHCC97-L cells were established from the same parent cell line, MHCC97. After orthotopic inoculation of MHCC97-H and MHCC97-L to recipient nude mice, respectively, spontaneous pulmonary metastasis occurred in 100 and 40% (4Li Y. Tang Z.Y. Ye S.L. Liu Y.K. Chen J. Xue Q. Chen J. Gao D.M. Bao W.H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97..World J. Gastroenterol. 2001; 7: 630-636Google Scholar). A series of progressively more metastatic HCC cell strains designated as HCCLM1–5 were also established via repeated in vivo selection from MHCC97-H cells (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). These cells were cultured in Dulbecco’s modified Eagle’s medium (Life Technologies, Grand Island, NY) supplemented with 10% fetal calf serum (Hyclone, Logan, Utah) at 37 °C in 5% CO2. Sample preparation was performed as described previously (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar). Protein concentrations were determined using modified Bradford assay (14Link A.J. 2-D Proteome Analysis Protocols. Humana Press, Totowa, NJ1999: 99-103Google Scholar). All samples were stored at −80 °C prior to electrophoresis. 2-DE was performed with the PROTEAN isoelectric focusing (IEF) system and PROTEAN xi II system (Bio-Rad, Hercules, CA) as previously described (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar). Fifty micrograms of total proteins were run with an IEF system using 17-cm pH 3–10 ReadyStrip (Bio-Rad). The total Vh was 47,000∼52,000. SDS-PAGE was run at constant current of 10 mA for 30 min, and the current was switched to 25 mA till the bromphenol blue frontier reached the bottom of the gels. The proteins were detected with silver staining. For preparative 2-DE, 400 μg of proteins were separated by IEF as described above, and the total Vh was 90, 000∼120, 000. After electrophoresis in the second dimension, the gels were stained by a modified silver staining method compatible with mass spectrometry analysis (15Yan J.X. Wait R. Berkelman T Harry R.A. Westbrook J.A. Wheeler C.H. Dunn M.J. A modified silver staining protocol for visualization of proteins compatible with matrix-assited laser desorption/ionization and electrospray ionization mass spectrometry..Electrophoresis. 2000; 21: 3666-3672Google Scholar). Gels were scanned using a GS-710 imaging densitometer (Bio-Rad) and analyzed by PDQuest software (Bio-Rad). Protein identification was performed as described previously (16Shevchenko A. Wilm M. Vorm O. Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels..Anal. Chem. 1996; 68: 850-858Google Scholar) with some modifications. Briefly, spots were cut out from the gels, destained for 20 min in 30 mm KCN/100 mm Na2S2O3 1:1 (v/v), and washed with Milli-Q water until the gels became clear. Background gel was cut out and used as a negative control. Then they were kept in 0.2 m NH4HCO3 for 20 min, lyophilized, and digested overnight in 12.5 ng trypsin/μL in 0.1 m NH4HCO3. The peptides were extracted three times by 50% acetonitrile with 0.1% trifluoroacetic acid and lyophilized. Then 0.5 μL of peptides was mixed with the α-cyano-4-hydroxycinnamic acid matrix (Sigma, St. Louis, MO), applied onto the target, air dried, and analyzed by Bruker REFLEX III MALDI-TOF mass spectrometer (Bruker-Franzen Analytik, Bremen, Germany). Protein identification using peptide mass fingerprint was performed by Mascot search (www.matrixscience.com; MatrixSicence Ltd, London, UK) against the NCBI nonredundant protein database. The species is Homo sapiens. The errors in peptide masses were in the range of 0.01–0.1%. One missed tryptic cleavage site per peptide was allowed during the search. Cysteines were carboamidomethylated, and methionines were considered as oxidation. Proteins matching more than four peptides and Mascot scores higher than 63 were considered significant (p < 0.05). Protein was separated by 10% SDS-PAGE or by 2-DE as described above and electroblotted to Immobilon-P membrane (Millipore, Bedford, MA). After treating with 5% fat-free dried milk in 1× TBST (25 mm Tris, pH 7.5, 150 mm NaCl, 0.05% Tween-20, and 0.001% thimerosal) for 1 h at room temperature, the membranes were incubated with mouse anti-human CK19 (1:1000 dilution; Dako, Glostrup, Denmark) for 1 h at room temperature, followed by horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Actin was used as an internal positive control. Target proteins were detected by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech, Piscataway, NJ). Triplicate cultures of MHCC97-H and MHCC97-L cell clones were washed in phosphate-buffered saline (pH 7.4) and fixed in methanol at −20 °C for 5 min. The cells were first incubated with mouse anti-human keratin 8, 18, and 19 primary antibodies (Dako) (1:100 dilution for CK8 and CK18, 1:50 dilution for CK19) for 30 min at 37 °C, then incubated with fluorescein isothiocyanate-conjugated anti-mouse IgG secondary antibody (1:300 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min at room temperature. The negative control was performed without adding primary antibody. The cells were washed in phosphate-buffered saline three times each for 3 min. The slides were sealed in glycerin, and CK expression and layout pattern was observed by fluorescent microscopy (Zeiss, Oberkochen, Germany) at 450-nm wavelength. One hundred two HCC specimens from 88 male and 14 female patients with an average age of 51 (range 26–72) were obtained from the Eastern Hepatobiliary Surgery Hospital in the period of May 2002 to July 2003. Ninety-two (90.2%) patients had serological evidence of hepatitis B virus infection. The α-fetoprotein (AFP) level was above 25 μg/liter in 77 cases (75.5%). Tumor size was smaller than 5 cm in 30 patients and larger than 5 cm in 72 patients. Eighty-two patients (80.4%) had complication of cirrhosis. There were 27 cases (26.5%) in TNM stage I (T1N0M0) and II (T2N0M0) and 75 (73.5%) in stage III (T3N0M0, T4N0M0 and T1–4N1M0) and IV (any T, any N and M1) (17Pollock R.E. Manual of Clinical Oncology, Wiley-Liss, New York2002: 166-167Google Scholar). Capsule invasion was found in 64 cases, macroscopic portal vein tumor emboli in 9 patients, and microscopic surrounding liver vascular cancer emboli in 19 patients. Metastatic satellite nodules were found in 12 cases. After routine pathological study, these specimens were processed for immunohistochemical detection of CK19 expression with anti-CK19 primary antibody (1:500 dilution; Dako). The slides were lightly counterstained with Harris hematoxylin and viewed under a light microscope. Uninfected liver tissues from surgically resected hepatic cavernous hemangiomas were used as a negative control. Preoperative liver function tests were normal in all these patients and were negative for hepatitis B and C. An irrelevant primary antibody (pre-immune rabbit serum) was used to replace CK19 primary antibody on a consecutive section from CK19-positive staining followed by hematoxylin and eosin staining. CK19-positive staining was categorized as HCC-CK19+ if over 25% of the tumor cells were positively stained and as HCC-CK19− if stained otherwise. Highly spontaneous metastatic nude mice model of human HCC was used to study the relationship between serum CK19 fragment CYFRA 21-1 levels and tumor progression. A total of 5 × 106 cells/0.2 ml of HCCLM3 cell strain (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar) were injected subcutaneously into each of 30 4-wk-old male BALB/c-nu/nu nude mice obtained from the Shanghai Institute of Materia Medica, Chinese Academy of Science, and kept in specific pathogen-free facilities. It is more efficient to choose HCCLM3 cells for the establishment of the mouse model because it could produce prominent lung metastasis after subcutaneous injection (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). After tumor cell inoculation, the mice were randomly divided into six groups of five mice in each group. At the end of the second, third, fourth, fifth, sixth, and seventh week, one group of mice was sacrificed respectively under deep anesthesia by peritoneal injection of 3% phenobarbital chloride. The blood was drawn and centrifuged at 10,000 × g at 4 °C for 10 min to separate the serum and then kept at −80 °C. The tumor weight of each mouse was recorded. The lungs were fixed in 10% neutral formalin solution and processed for conventional pathological study. Pulmonary metastasis was recorded according to the procedures used before (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). Serum CYFRA 21-1 levels in nude mice model of human HCC were determined by radioimmunoassay using a commercial detection kit (ELISA-CYFRA 21-1; CIS Bio International, Gif-Sur-Yvette, France) in accordance with the protocols. Student’s t test and Fisher’s exact test were used to compare the clinicopathologic parameters between HCC-CK19+ and HCC-CK19− groups for age, hepatitis B antigen, tumor size, serum AFP level, TNM stage, capsule invasion, metastatic satellite nodules, and blood vessel emboli. Values of p < 0.05 were considered statistically significant. For the comparison of serum CK19 levels in different animal groups, analysis of variance and q test was used. From cell culture to 2-DE, the experiments were repeated three times and silver-stained gels were analyzed by PDQuest software. The average protein spots detected were 1030 ± 113 in MHCC97-H and 1007 ± 107 in MHCC97-L. The scatter plots showed good correlation between these two kinds of cells with a correlation coefficient of 0.81, implying similarity in expression of most proteins and differences of only a small number of proteins between them (18Ding S.J. Li Y. Shao X.X. Zhou H. Zeng R. Tang Z.Y. Xia Q.C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.Proteomics. 2004; (in press)Google Scholar). A representative gel image was selected from MHCC97-L (Fig. 1 A). In total, 69 spots (including both housekeeping and differentially expressed proteins) were identified on the preparative silver-stained gels using MALDI-TOF-MS analysis (18Ding S.J. Li Y. Shao X.X. Zhou H. Zeng R. Tang Z.Y. Xia Q.C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.Proteomics. 2004; (in press)Google Scholar). Some of the identified proteins are shown in Fig. 1A. Among them, spot SSP 7615 was only present in MHCC97-H (Fig. 1B), and the MALDI-TOF mass spectrum of peptides derived from 7615 is shown in Fig. 1C. Mascot search using the peptide mass fingerprint data indicated that 18 peptides were matched with peptides from CK19, giving sequence coverage of 50% and a summary score of 240. Such results suggested that CK19 was the identity of spot 7615 with high confidence. CK8 and CK18 were also identified in MHCC97-H and MHCC97-L cells but without significant changes. To confirm the above proteomic result, we employed two-dimensional Western blot, which has the advantage of enhanced sensitivity and the ability to detect protein isoforms assigned from post-translational modifications. A trace amount of CK19 isoforms in MHCC97-L was detected, but its expression was much higher in MHCC97-H (Fig. 2 ). Furthermore, the immunofluorescene assay demonstrated that both MHCC97-H and MHCC97-L expressed CK8 and CK18 normally, with the same distribution and layout pattern, forming a well-extended filament network. However, the expression and distribution pattern of CK19 was quite different between these two kinds of cells, being well developed in MHCC97-H but almost invisible in MHCC97-L cells (Fig. 3 ).Fig. 3Immunofluorescence detection of CK IFs in MHCC97-H and MHCC97-L cells. A total of 1 × 104 cells were cultured on slide chamber for 24 h, washed, fixed, and treated with monoclonal antibodies against CK8, CK18, and CK19, followed by fluorescein isothiocyanate-conjugated secondary antibody, and viewed by immunofluorescent microscopy (1000×). The negative control was performed without adding primary antibody. Both CK8 and CK18, which are positive in HCC, were well developed in MHCC97-H and MHCC97-L, forming fine network pattern. In contrast, CK19 was aberrantly expressed in MHCC97-H but invisible in MHCC97-L cells.View Large Image Figure ViewerDownload (PPT) HCCLM1-5 cells, with progressively higher metastatic potential obtained from successive lung metastasis selections of MHCC97-H (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar), were examined for CK19 expression. As indicated in Fig. 4 , CK19 showed consistently increased expression from HCCLM1 to HCCLM5, suggesting a positive correlation of CK19 expression with their metastatic potentials. We further studied the CK19 expression in clinical HCC tissues using immunohistochemistry analysis. Among 102 HCC specimens, CK19 was positive in 12.7% (13/102) of the cases. When the CK19-positive group was compared with the CK19-negative group, more patients had poor tumor differentiation (grade III/IV tumors 13/13 (100.0%) versus 62/89 (69.7%), p < 0.001) and intrahepatic metastases (satellite nodules 5/13 (38.5%) versus 7/89 (7.9%), p < 0.05; tumor emboli in blood vessels 11/13 (84.6%) versus 17/89 (19.1%), p < 0.001). There was no significant correlation between CK19 expression with age, tumor size, and hepatitis B antigen seropositivity (p > 0.05) (Fig. 5 , Table I ).Table IRelationship between CK19 expression in tissue samples and clinicopathological characteristics of 102 HCC patientsCK19 positive (n = 13)CK19 negative (n = 89)p valueAge (years, median)54.749.9>0.05aStudent’s t test.HBsAgbHepatitis B surface antigen. positive92.3% (12/13)89.9% (80/89)>0.05cFisher’s exact test.Tumor size>5 cm69.2% (9/13)70.8% (63/89)≤5 cm30.8% (4/13)29.2% (26/89)>0.05cFisher’s exact test.AFP (>25 μg/liter)69.2% (9/13)76.4% (68/89)>0.05cFisher’s exact test.TNM stagingIII/IV100.0% (13/13)69.7% (62/89)I/II0.0% (0/13)30.3% (27/89)<0.001cFisher’s exact test.Capsule invasion61.5% (8/13)62.9% (56/89)>0.05cFisher’s exact test.Satellite nodules38.5% (5/13)7.9% (7/89)<0.05cFisher’s exact test.Vascular tumor embolidIncluding tumor emboli in the portal vein and small blood vessels.84.6% (11/13)19.1% (17/89)<0.001cFisher’s exact test.a Student’s t test.b Hepatitis B surface antigen.c Fisher’s exact test.d Including tumor emboli in the portal vein and small blood vessels. Open table in a new tab When the human HCC cell line HCCLM3 was injected into nude mice, tumors developed after 1 wk, showing aggressive growth. The tumor growth became accelerated from the third week on, and on the fifth week the mice showed signs of distress. Histopathological study of the lungs showed conspicuous metastases (Fig. 6 ). Tumor growth, lung metastasis, and serum CYFRA 21-1 levels are shown in Table II . The animal serum CYFRA 21-1 level increased in parallel with the progression of the engrafted tumor. Moreover, serum CYFRA 21-1 levels rose remarkably when pulmonary metastasis occurred (q test, p < 0.01).Table IIRelationship between serum CK19 level and lung metastasis in a nude mice modelWeek 2Week 3Week 4Week 5Week 6Week 7Tumor weight (g)0.31 ± 0.130.61 ± 0.121.43 ± 0.372.38 ± 0.923.74 ± 0.964.85 ± 1.02Lung metastasis rate (%)0020100100100Median no. of lung metastases000aOnly one mouse had lung metastases at week 4, and the total number of lung metastases was less than five, so the median number of lung metastases was 0.81118150Serum CK19 (μg/liter)4.79 ± 1.165.06 ± 1.218.55 ± 1.2540.71 ± 9.87bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).76.29 ± 20.00bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).95.94 ± 19.68bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).a Only one mouse had lung metastases at week 4, and the total number of lung metastases was less than five, so the median number of lung metastases was 0.b p < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test). Open table in a new tab A great deal of effort has been made to predict HCC behavior, but specific prognostic indicators are still lacking. Prognostic factors in HCC conventionally consist of staging with the TNM system and grading by tumor cellular differentiation (19Qin L.X. Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma.World J. Gastroenterol. 2002; 8: 385-392Scopus (290) Google Scholar). There are also other factors useful in prognosis but most of them are clinical. A large number of molecular biological factors have been shown to associate with the invasiveness of HCC and have potential prognostic significance including proliferating cell nuclear antigen, Ki-67, E-cadherin, catenins, urokinase-type plasminogen activator (uPA), uPA receptor, vascular endothelial growth factor, and AFP, etc (19Qin L.X. Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma.World J. Gastroenterol. 2002; 8: 385-392Scopus (290) Google Scholar, 20Weber J.C. Nakano H. Bachellier P. Oussoultzoglou E. Inoue K. Shimura H. Wolf P. Chenard-Neu M.P. Jaeck D. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metast